Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Rajbabu Pakala"'
Autor:
Shreejana Pokharel, Kenneth M. Kent, Rajbabu Pakala, Michael A. Gaglia, Rebecca Torguson, Zhenyi Xue, William O. Suddath, Ron Waksman, Augusto D. Pichard, Lowell F. Satler
Publikováno v:
Cardiovascular Revascularization Medicine. 14:76-80
Aims We hypothesized that patients with a history of either alarming or nuisance bleeding events, compared to those with no history of bleeding, would have lower levels of on-treatment platelet reactivity (aspirin and a thienopyridine). Methods and R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccc0bab96a979f4a703db78e9e893738
https://doi.org/10.1016/j.carrev.2012.12.005
https://doi.org/10.1016/j.carrev.2012.12.005
Autor:
Augusto D. Pichard, Israel M. Barbash, Zhenyi Xue, Ana Laynez, Rebecca Torguson, Camille Hauville, Gabriel Sardi, Lowell F. Satler, Rajbabu Pakala, Ron Waksman
Publikováno v:
Catheterization and Cardiovascular Interventions. 81:759-765
Objectives This study aimed to analyze the use of everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES) in an unrestricted diabetic population and to compare the performance of these two drug-eluting stents. Background EES have demonstr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::095712968c2454e3eee5127685f9b481
https://doi.org/10.1002/ccd.24438
https://doi.org/10.1002/ccd.24438
Autor:
Gabriel Sardi, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Rajbabu Pakala, Zhenyi Xue, Michael A. Gaglia, William O. Suddath, Rebecca Torguson, Ron Waksman
Publikováno v:
Journal of Interventional Cardiology. 24:529-534
Background:High on-treatment platelet reactivity is an established risk factor for adverse cardiac events in patients taking clopidogrel following percutaneous coronary intervention (PCI). Methods:Two hundred patients underwent platelet reactivity te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f385424041350475e0d7de7cd09852dd
https://doi.org/10.1111/j.1540-8183.2011.00670.x
https://doi.org/10.1111/j.1540-8183.2011.00670.x
Autor:
Rebecca Torguson, Augusto D. Pichard, Michael Mahmoudi, Gabriel Sardi, Michael A. Gaglia, Kenneth M. Kent, William O. Suddath, Zhenyi Xue, Rajbabu Pakala, Ron Waksman, Lowell F. Satler
Publikováno v:
The American Journal of Cardiology. 108:766-771
Previous research has suggested that obesity is associated with increased high on-treatment platelet reactivity. We therefore tested platelet reactivity in 251 patients with VerifyNow P2Y12, vasodilator-stimulated phosphoprotein phosphorylation, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b15e88825f03ef708c83b3428a4e901a
https://doi.org/10.1016/j.amjcard.2011.04.029
https://doi.org/10.1016/j.amjcard.2011.04.029
Autor:
Rajbabu Pakala, Ron Waksman
Publikováno v:
EuroIntervention. 5:F36-F42
Advances in coronary stent technology, including refinement of the stent alloy, strut thickness, stent geometry, passive coating, and drug elution, have dramatically enhanced the safety and efficacy of percutaneous coronary intervention (PCI) with st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15d4c9f51cfbaeb9633f9525d72a271d
https://doi.org/10.4244/eijv5ifa6
https://doi.org/10.4244/eijv5ifa6
Autor:
Rosanna C. Chan, Rajbabu Pakala, David Hellinga, Ron Waksman, Rufus Seabron, Frank D. Kolodgie, Mickey Scheinowitz, Richard Baffour, Renu Virmani
Publikováno v:
Cardiovascular Revascularization Medicine. 10:110-116
Background Injection of bone marrow cells (BMC) and endothelial progenitor cells (EPC) or application of stem-cell-mobilizing factors has been associated both with reduction or exacerbation of atherosclerosis and with unstable plaque phenotype. The d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1222de3a270936bb7ec3b7060d9f12a
https://doi.org/10.1016/j.carrev.2009.02.001
https://doi.org/10.1016/j.carrev.2009.02.001
Autor:
Axel de Labriolle, Laurent Bonello, Gilles Lemesle, Ron Waksman, Rajbabu Pakala, Mickey Scheinowitz
Publikováno v:
Catheterization and Cardiovascular Interventions. 73:643-652
Since the first clinical angioplasty by Gruntzig in 1977, restenosis has been the primary drawback of percutaneous coronary intervention (PCI). In the balloon era. restenosis was correlated with elastic recoil and negative remodeling of the arterial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0e9e44c2995075d2d1bcdb9f27b62a3
https://doi.org/10.1002/ccd.21895
https://doi.org/10.1002/ccd.21895
Autor:
Fermin O. Tio, Rajbabu Pakala, Tina L. Pinto Slottow, Ron Waksman, Rachel J. Lovec, Teruo Okabe, Anh B. Bui, David Hellinga
Publikováno v:
Cardiovascular Revascularization Medicine. 9:248-254
Absorbable metallic stents (AMS) composed of magnesium alloy were designed to complete degradation within 90-120 days. Among the potential advantages of these stents, when compared to conventional stents, are the elimination of late stent thrombosis,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a9b4d1c6a8664caf103fab1fb1f370c
https://doi.org/10.1016/j.carrev.2008.04.001
https://doi.org/10.1016/j.carrev.2008.04.001
Autor:
Jeffrey A. Vasek, Pauline McEwan, David Hellinga, Rajbabu Pakala, Steven J. Rychnovsky, Rufus Seabron, Frank D. Kolodgie, Travis I. Moore, Renu Virmani, Rob Scott, Ron Waksman
Publikováno v:
Journal of the American College of Cardiology. 52:1024-1032
ObjectivesThe purpose of this study was to determine how photodynamic therapy (PDT) promotes stabilization and reduction of regional atherosclerosis.BackgroundPhotodynamic therapy, a combination of photosensitizer and targeted light to promote cell a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f88fcd650ed4be0d88fd11f15633d570
https://doi.org/10.1016/j.jacc.2008.06.023
https://doi.org/10.1016/j.jacc.2008.06.023
Autor:
Rajbabu Pakala
Publikováno v:
Cardiovascular Revascularization Medicine. 9:166-178
Urotensin II (U-II) is a powerful vasoconstrictor peptide with a potency greater than that of endothelin 1. Its plasma level correlates positively with body weight and is raised in diabetes, renal failure, hypertension, and other cardiovascular disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38d8cf5c46c8bf3daecd8d40708691e3
https://doi.org/10.1016/j.carrev.2008.02.001
https://doi.org/10.1016/j.carrev.2008.02.001